These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4229180)

  • 1. In vitro and in vivo studies with trasylol, an anticoagulant and a fibrinolytic inhibitor.
    Dubber AH; McNicol GP; Uttley D; Douglas AS
    Br J Haematol; 1968 Jan; 14(1):31-49. PubMed ID: 4229180
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative studies of fibrinolytic inhibitors in vitro.
    Maki M; Beller FK
    Thromb Diath Haemorrh; 1966 Dec; 16(3):668-86. PubMed ID: 4231539
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative activities of amino acid and polypeptide inhibitors on natural and synthetic substrates.
    Skoza L; Tse AO; Semar M; Johnson AJ
    Ann N Y Acad Sci; 1968 Jun; 146(2):659-72. PubMed ID: 4239440
    [No Abstract]   [Full Text] [Related]  

  • 4. A new broad spectrum inhibitor of esteroproteases, 4-(2-carboxyethyl) phenyl-trans-4-aminomethyl cyclohexane carboxylate hydrochloride (DV 1006).
    Maki M; Sasaki K
    Tohoku J Exp Med; 1972 Mar; 106(3):233-48. PubMed ID: 4261023
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on the mechanism of action of inhibitors of the fibrinolysin system.
    Ambrus CM; Ambrus JL; Lassman HB; Mink IB
    Ann N Y Acad Sci; 1968 Jun; 146(2):430-47. PubMed ID: 4239437
    [No Abstract]   [Full Text] [Related]  

  • 6. Further evidence for an active center in streptokinase-plasminogen complex; interaction with pancreatic trypsin inhibitor.
    Reddy KN; Markus G
    Biochem Biophys Res Commun; 1973 Apr; 51(3):672-9. PubMed ID: 4267404
    [No Abstract]   [Full Text] [Related]  

  • 7. [Inhibition by ethanol and acetaldehyde the plasmin activity and plasminogen activation induced by urokinase and streptokinase].
    Roszkowska-Jakimiec W; Jurkowski J; Ostrowska H; Worowski K
    Rocz Akad Med Bialymst (1989); 1988-1989; 33-34():53-66. PubMed ID: 2979011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the mechanism of action of synthetic antifibrinolytics. A comparison with the action of derivatives of benzamidine on the fibrinolytic process.
    Landmann H
    Thromb Diath Haemorrh; 1973 May; 29(2):253-75. PubMed ID: 4271586
    [No Abstract]   [Full Text] [Related]  

  • 9. THE INHIBITION OF TRASYLOL OF FIBRINOLYTIC ACTIVITY ASSOCIATED WITH CARDIOVASCULAR OPERATIONS.
    TICE DA; WORTH MH; CLAUSS RH; REED GH
    Surg Gynecol Obstet; 1964 Jul; 119():71-4. PubMed ID: 14179354
    [No Abstract]   [Full Text] [Related]  

  • 10. The activating mechanism of human plasminogen through streptokinase. Inhibition experiments with BAL.
    Auerswald W; Doleschel W
    Pharmacology; 1972; 8(4):232-4. PubMed ID: 4266631
    [No Abstract]   [Full Text] [Related]  

  • 11. The formation of an enzymically active complex between DFP-inhibited plasmin and streptokinase.
    Tomar RH; Beisswenger JG
    Proc Soc Exp Biol Med; 1973 May; 143(1):127-30. PubMed ID: 4267367
    [No Abstract]   [Full Text] [Related]  

  • 12. On the significance of "anti-streptokinase" in streptokinase-induced thrombolytic therapy.
    Bruhn HD
    Thromb Diath Haemorrh; 1973 Sep; 30(1):221-2. PubMed ID: 4274800
    [No Abstract]   [Full Text] [Related]  

  • 13. Trypsin inhibitor excretion due to fibrinolytic activation of cat plasma.
    Mootse G; Cliffton EE
    Proc Soc Exp Biol Med; 1968 Oct; 129(1):70-3. PubMed ID: 4234874
    [No Abstract]   [Full Text] [Related]  

  • 14. Biological activities of leupeptins.
    Aoyagi T; Miyata S; Nanbo M; Kojima F; Matsuzaki M
    J Antibiot (Tokyo); 1969 Nov; 22(11):558-68. PubMed ID: 4243683
    [No Abstract]   [Full Text] [Related]  

  • 15. INTRAVASCULAR CLOTTING AND SPONTANEOUS FIBRINOLYSIS.
    KOLLER F
    Acta Haematol; 1964 Apr; 31():239-46. PubMed ID: 14169390
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibitors of fibrinolysis: evidence of some instances of mutual potentiation.
    Coccheri S; De Rosa V
    J Clin Pathol; 1972 Jul; 25(7):627-8. PubMed ID: 4262716
    [No Abstract]   [Full Text] [Related]  

  • 17. Distinction of serum inhibitor of activator-induced clot lysis from alpha1-antitrypsin.
    Aoki N; Moroi M
    Proc Soc Exp Biol Med; 1974 Jun; 146(2):567-70. PubMed ID: 4275737
    [No Abstract]   [Full Text] [Related]  

  • 18. [Theoretical bases of thrombolytic therapy].
    Verstraete M
    Pathol Biol (Paris); 1975 Mar; 23(3):239-45. PubMed ID: 124849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasminogen-plasmin system. 3. Kinetics of plasminogen activation and inhibition of plasminogen-plasmin system by some synthetic inhibitors.
    Iwamoto M; Abiko Y; Shimizu M
    J Biochem; 1968 Dec; 64(6):759-67. PubMed ID: 4238017
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of fibrinolytic system by liquoid (polyanetholesulfonate). A contributing factor in the liquoid-induced renal cortical necrosis.
    Gilboa N; Ryan TJ; MacColl R
    Haemostasis; 1987; 17(3):162-70. PubMed ID: 3038710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.